Cloning and functional expression of a cDNA encoding a mouse type 2 neuropeptide Y receptor  by Nakamura, Motonao et al.
ELSEVIER Biochimica et Biophysica Acta 1284 (1996) 134-137 
Short sequence-paper 
Cloning and functional expression of a cDNA encoding a mouse type 2 
1 neuropeptide Y receptor 
Motonao Nakamura *, Yoshiko Aoki, Daisuke Hirano 
Life Science Research Laboratory, Japan Tobacco Inc., 6-2 Umegaoka, Aoba-ku, Yokohama, Kanagawa 227, Japan 
Received 8July 1996; accepted 12 August 1996 
Abstract 
A cDNA clone homologous with the human neuropeptide Y (NPY)-Y2 receptor has been isolated from a mouse brain cDNA library. 
Analysis of the predicted amino-acid sequence indicates that the polypeptide ncoded by this cDNA is 94% homologous to the human 
NPY-Y2 receptor. In Chinese hamster ovary (CHO) cells expressing the mouse NPY-Y2 receptor, an increase in intracellular Ca 2÷ and 
inhibition of forskolin-induced cAMP accumulation were observed ue to stimulation with NPY, NPY-(13-36) and peptide YY, but not 
with pancreatic polypeptide or [Leu31,Pro34]NpY. The fact that the NPY-induced increase in intracellular Ca 2+ and inhibition of 
forskolin-induced cAMP accumulation were eliminated by pretreatment with pertussis toxin suggests that the NPY-Y2 receptor couples to 
PTX-sensitive G-protein(s), probably Gi/Go, in CHO cells. 
Keywords: Molecular cloning; Neuropeptide Y; Y2-type receptor; (Mouse) 
Neuropeptide Y (NPY) is an important regulator in the family in order of potency to displace 125I-NPY or ~25I-pYY 
central and peripheral nervous system. The pancreatic binding, NPY receptors have been classified into at least 
polypeptide family includes NPY, pancreatic polypeptide four receptor subtypes [4,5]: (1) the Y1 type binds NPY, 
(PP), and peptide YY (PYY), all of which are 36-amino- PYY, and an analog of NPY modified at residues 31 and 
acid peptides characterized by a hairpin loop. NPY is 34 ([Leu31,Pro34]NpY)> PP and the NPY peptide C- 
widely distributed in the brain [1,2] and the peripheral terminal fragment (NPY-(13-36)); (2) the Y2 type binds 
nervous system [3], and is often co-localized with nor- NPY ,  PYY ,  and NPY- (13-36)  > PP and 
epinephrine. NPY modulates numerous physiological pro- [Leu31,Pro34]NpY; (3) the Y3 type binds NPY > PYY; 
cesses, including appetite, anxiety, blood pressure, and and (4) the Y4 type binds PP > [Leu31,Pro34]NpY > NPY. 
circadian rhythm [4,5]. PYY is localized primarily in in- Recently, Yl-type receptor cDNAs (human [6,7], mouse 
testinal endocrine cells and functions as a circulating hor- [8,9], rat [10], and Xenopus laevis [11]) and Y4-type 
mone with elevated postprandial levels; small amounts are receptor cDNAs (human [12,13] and mouse [14]) were 
also found in central and peripheral neurons [4,5]. Studies isolated and found to have sequences imilar to members 
of various organs and cell types with peptide fragments of of a G-protein coupled receptor superfamily. Moreover, 
NPY have indicated that multiple NPY receptor subtypes Rose et al. [15] and Gerald et al. [16] cloned a human NPY 
exist. Based on a ranking of the pancreatic polypeptide receptor, which was similar in its ligand binding properties 
to the pharmacologically defined Y2 type. However, stud- 
ies of tissue distribution using the human clone have been 
Abbreviations: NPY, neuropeptide Y; PYY, peptide YY; PP, pancre- hindered by the limited availability of human tissues. Here 
atic polypeptide; RT-PCR, reverse transcriptase-polymerase chain reac- 
tion; fura-2/AM, fura-2 pentaacetoxymethyl ester; CHO cells, Chinese we describe the homologous screening of a mouse Y2-type 
hamster ovary cells; PTX, pertussis toxin; G-protein, guanine nucleotide- receptor. The clone has been functionally expressed in 
binding protein; kbp, kilobase pair(s); bp, base pair(s). Chinese hamster ovary (CHO)-K1 cells where its activa- 
* Corresponding author. Fax: +81 45 9726206; e-mail: tion mobilizes intracellular Ca 2+ and inhibits forskolin- 
nakamura@tcrl.jti.co.jp, stimulated cAMP accumulation. 
f The nucleotide sequence data reported in this paper have been 
submitted tothe DDBJ/GenBank/EMBL Data Bank under the accession To obtain a mouse homologue of the NPY-Y2 receptor, 
number D86238. a mouse brain cDNA library (AZAPII, 3. l0 5 plaques) 
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Mouse Y2: MVLKMGPVGAEAD~V. KVEPYGPG~RGELPPDPEPELIDSTKL 50 
Human Y2 : MGPIGAEADEN~q'VEE~3/EQYGPQ. TTPRGELVPDPEPELIDSTKL 46 
Mouse Y1 : MNSTLFSKVENHSIHYNASENSPLLAFENDDCHLP 35 
-276 Mouse Y4: ~TSHFLAPLFPGSLQGKNGTNPLDSPYNFSDC£QDS 37 
. . . . . . . . . . . . . . . . . . . . . . . .  GGCACGAGCTCTGAGCTGTGCAGTGCGGGGTCCCTG 
ATCGAGTGGCTTTAGAGGTCCACCGAGAAGCCGAGCAGGCACAGCATTGCAGCTGTTCCG Mouse Y2: VEVQVIL IL~CSI I~LV~HWI~VA~ i01 
CTTTGCCGCTCCTGCTTCTGATCTCACTTGCTGGCTCACACCAAATCGGACCTGCTTTGG Human Y2 : IEVQVVL ILA~SI I~ i l i~L~I~VA~ 97 
GTGCCTCCCAGGTACTGTCTCCAGACTGGCTGeTTAGATAATCCCTTGCTTGAAATTCCT Mouse Y1 : L A V I F T ~ V I ~ I I L K ~ L ~ i S F S  ~ 86 
C~ATTCCTeATeTSAGAAGGAAACGCGCAAGAGTCAATACAGTAAGCCAAGTGAGAGTGA Mouse Y4: AELLAFIITIISIETII.iLCLI"V~RQ~'K ~ 88 
1 
X 
~TGGT~C~G~OATGG~OCC~A~e~;~O~ Mouse Y2: iVN~- IN I~ I I I ;4~I Iml IcvPY~uvQi r I@V~Iu l  ,5~ 
w v L K M G P V G A E A D E N Q T V E V Human Y2: I]VNTI.IH[F][Llli[,I~I~I]~I[P~TPY/IIGLAVQiiTII]]I'VI[[LI~] 148 
61 # Mouse YI: IYA F~VSIT~FC~IH 137 
AAAGTGGAGCCCTATGGGCCAGGGCACACTACTCCTAGAGGTGAGTTGC CC CTGATCCG 
K V E P Y m P G H T T P R G E L P P D P Mouse Y4 : ~ Y I I ~ V I i ~ L  ~ 139 
121 xx x~'x 
GAGCCGGAGCTCATAGACAGCACCAAACTGOTeGAGGTGCAGGTGATCC¢CATATTGGCC Mouse Y2: RRC~SKISKRISFLI~I~ISALLASILAIFREYSLIEIIPD.. 201 
E P E L " D S T K L V E V Q V ;~ L I L A Human Y2: iR(~SKISKRISFLI~L~ISALLAS~.AIFREYSLIEIIPD., i97 
181 Mouse YI: iQLilNPRGWRPNNRHAYIG~VIICLAVASSLITVIYQILTDEPFQNVSL 188 
TACTGCTCCATCATCTTGCTAGGGGTAGTTGGCAACTCCCTGGTAATCCATGTGGTAATC Mouse Y4: IQL I INP I~WKPSIFQA~I IF ISCFLSL~ANSTLND~SK 190 
Y C S I I L L G V V G N S L V I H V V I XV 
~1 Mouse Y2: ...liE.. Iv,qlm~GESKSWO'rvls~Id~IIoIIs~'@L4~ ~4~ 
AAATTCAAGAGCATGCGCACAGTAACCAACTTTTTTATTGCCAACCTGGCTGTGGCGGAT Human Y2 : ...IE.. IV~/WPGEEKSIYGTV~LSSiLILiVLiGI~FSIf~W 245 
K F K S M R T V T N F F I A "N L A V A D Mouse YI: AA. iK .D~KFPSD. .$HRLS. i~LL IVL~EGiCF~IC~IY  234 
301 Mouse Y4: VVE~EDKV~WSWSSD. .F~HRL I .~ 238 
C TTTTGGTGAACACCC TGTGC C TGCCATTCACTC TTACCTATACCTTGATGGGAGAGTGG ~ ~  
L L V N T L C L P F T L T V T L M G E W Mouse Y2: S~RNHVSPGAASDHY~RH..i~TK. LAV 295 
361 H~ Y2: SI~}~,]VSPGALNDHYI-KIIRQ..]] 'FI 'K. it/~LAV 29i 
AAAATGGGTCCGGTCTTGTGCCATTTGGTGCCCTATGCCCAGGGTCTGGCGGTACAAGTG Mouse YI : I~DKIRDSK~.~SSE '~RIN I i LS I~mi iT I~F  285 
m M G V V L C H L V p W A O G L A V O V Mouse V4: Q~RQ~VFHAHACSS.BA~RIN~_~~__ .  " 288 
TCCACAATAACTTTGACAGTCATTGCTCTGGACCGCCATCGTTGCATTGTCTACCACCTG Mouse Y2: iIDSHVLD AFR 345 
s T I T L T V X A L D R H R C I V Y H L Human Y2: ~DSHVLD~~/ i i~ ,RKAFLSAFR 341 
481 Mouse YI: FNHQI IATC~U/~~[~'QRDLQFFFNF 336 
GAGAGCAAGATCTCCAAOCGA~TCAGCTTCCTGATCATTGGCCTGGCCTGGGGCATCAGC Mouse Y4: ~YQEAIPACHGhl I~C~I i~U.~IFKKDIKALVLT  339 
E S K Z S K R I S F L I I G L A W G I S %~ 
541 Mouse Y2: ~£~LDAIHS~/SITFKAKKNLE~GPTDSFSEATNV 385 
GCTCTGCTGGCAAGTCCACTGGCCATCTTCCGGGAATACTCCCTGATTGAGATCATTCCT Human Y2: ~ILDAIHSIVSVTFKAKKNLEVRKNSGPNDSFTEATNV 381 
A L L A S P L A I F $ E Y S L I E I I P Mouse YI: ~SRDDDY~IA~ST~fDVSKTSLKQASPVAFKKIS~DNEKV 382 
6Ol Mouse Y4: IriCR~PQGESliLPLSTVHTDLSKGS~8,HGSKSNFI 375 
GACTTTGAGATTGTGGCC TGTACCGAGAAGTGGCC TGGGGAAGAGAAGAGTGTGTATGGT 
D m E I V A C T m K W P G E E K S V Y G Pig. 2. Alignment of the predicted amino-ac id  sequence  o f  the  mouse  Y2  
661 
ACAGTCTACAGCCTTTCCACCCTGCTCATCCTGTACGTTTTGCCTCTGGGCATCATATCT receptor with the human Y2 [15,16], the mouse YI [8,9] and the mouse 
T V Y S L S • L n i L Y V n ~ L ~ ~ z s Y4 [4] receptor sequences. Periods represent spaces added for proper 
721 
TTCTCCTACACCCGTATCTGGAGTAAGCTGAGGAACCACGTCAGTCCTGGAGCTGCAAGT alignment. Numbers correspond to the amino-acid positions of  each 
F S Y T ~ Z ~ s ~ L R ~ H v s ~ G A ~ S receptor. The seven putative transmembrane domains are underlined and 
781 
GACCATTACCATCAGCGAAGGCACAAAATGACCAAAATGCTGGTGTGCGTGGTAGTGGTG numbered I -V I I .  Residues identical among the four receptors are shaded 
~ Y n Q R ~ n K ~ ~ K ~ n v ¢ v v v v in gray. 
TTTGCAGTCAGCTGGC TACC CCTC CACC-CCTTCCPa~.C TCGCTGTGGACATCGACAGC CAC 
F A V S W L P L H A F O L A V D I D S H 
901 
GTC CTGGACCTGAAGGAGTACAAACTCATCTTCACCGTGTTCCACATTATCGCCATGTGC 
V L D L K E Y K L I F T V F H I I A M C 
961 was screened with a 867-base pair (bp) PCR-derived probe 
s • r ;, ~ ~ ~ L ~ o ~ ~ ~ s ~ y ~ ~ ~ r spanning amino acids 93-381 of the human NPY-Y2 
~o~i  receptor [6,7]. One positive clone, referred to in this report CTC TCGGCCTTC CGCTGTGAGCAGAGGTTGGATGCCATTCACTCGGAGGTGTCTATGACC 
s ~ ~ ~ c s ~ ~ L D ~ ~ ~ s ~ v s ~ • as mY2, hasa3400-bp inser tDNAconta in inga  l155-bp 
1081 
~c~c~c~o~ce~G~c~.~c~c~eecc~c~,c~c~c~ open reading frame (Fig. 1). Since analysis of the pre- 
F K A K K N L E V K K N N G P T D S F S 
~z~ dieted amino-acid sequence indicates that the polypeptide 
GAGGCTACCAATGTGTAA 
~ • ~ v • encoded by this eDNA has seven transmembrane regions 
GGACACAGGTGTGAAAGCACATGGGTGAATTGTAACCAGCGCTGCCAATCTGGTTAGGGA 
AGGTTTTCTGGCCAGTGCATGCAGACCTCCCATTGTATTGACTCAAAAAGCAACAGAACC typical of G-protein coupled receptors and is 94% homolo- 
~cccee~c~c~c~e~c~crc~e~o~G~-~c~ gOUS to the human NPY-Y2 receptor [6,7], it is thought to 
ATTGC CATGGCACAACGTTCTGATTACCGATGCTTGGATTGTAGGTTGAATTCTGAGTAG 
AGAAGGGAAGG~CAGAAACAAGGAGTTGGCACCAC-CATGGTTAA~GGGAGAAGTAA be the mouse homologue of the NPY-Y2 receptor (Fig. 2). 
GTGTTATCTCCTGAGAGCCACAGTAGGATCTGCATCCAGGCACACTGTGGACTCCATGGG 
CTCCCCTCATCACTTGATGAAAAGCTGCTA~CAACTCAGATTTCCCTAGGGAGCTACAG The cytoplasmic tail of this receptor contains five ser ine  
GCTCTCTGTTAGGGTGTTTTGGTTTTATTGTGTTTACCTAAGATGAAACC CAAATGAGAA 
TGCTATAGGTAAACATGGCTTGCTACCTAAGGCGGTGACTTCA~GATAACGTCAAGAGAA residues and three threonine residues, which are possible 
TAAACACATTGCTATACGAGTAATGTTTCGGCAATGATGGGAGAGATTC AATATAATCA 
GTGAGCAATTAGTTGTTGTTCAGATCAAATGCACTACTGTTGAAAGTTTGTTTTTTAGTT phosphate acceptors and which are also observed in the 
C AGAAT C AAAAT C TGAAATTATCATAC TGAAAAGGAATGAAAACAATTGC TTTATTTC TG 
TAATAGCCATTCCTGCTTAGGTAGATACTGTTTGGATGACA~GCGAGCA&CTCAGCTCTT human NPY-Y2 receptor. Furthermore, there seems to be 
C TGTTTCTTGCTAACTGCTAAAGCCTTTTGGAACCACACAACTTTTGTTACCATTCCTGC 
ATGAGAGCA.A.ACAAAGTTCACACTAAAAGTTAAATCAGACTAAA&CATAATTTTGTAACA one N-linked glycosylation site in the N-terminal domain 




TAT TT TTGGTAACATAAATACATATACAAAA CA7%AAGCATATTC TATA~ATAGGGAAGCA 
TTAGAAAATTTTATTT~TAGTTTTATGAATATAGCTTTTATTTCAAAGGTACCCAGCCC 
AAAGATAATTAAAAC TC T AT TTT~TTCACACAGA~-%AGTAC GAAA~.ATGAGATG TTAAAA 
TAGTTGCACTTCTCTGGATGCTGACGTTTCAGTGTAGGCATATTTTTTGTAAATATGGCA 
GAATCTGTGTGTATATTCCTCACAATTTAGAAATATTTGATGTAGTCTAATATTTAGTTA 
TGATATTAATTTTGTATATATATTTAAATCTCAGACTCTGGCTGTTATTAAATTCCTTTC Fig. 1. The nucleotide sequence of  cloned mY2 and the deduced amino- 
AGTGTGGAAATA~GATTGGTCTCAAAGTGAATTGTTCTTCTAGAGTACTGAAAAGGAA acid sequences for the encoded mouse NPY-Y2 receptor. The predicted 
TAAAACACCAGAAGAAAAAAATGAATCTAAGGTGGAACGGGAAGTCCACCTTATACACTG 
CTGTCTGAAGTGAATCGTTGAACTATAAAAGACATCTTTCCTGTTGGACTCTGCACAGTC amino-acid sequence is shown in single-letter codes under the nucleic 
ATTCTGAAGGAGCTTTTTACTTTTCTATGTGTAAGA~AC~GCTTAAGATCTTAGTAGAA acid sequence. The seven putative transmembrane domains are under- 
GGTTGTTGTGAAGTCTTTATGCCCCTTGCAGATTTCCTATCCTGTACAAAACCTGTCTGT 
TACTGTGACTCCGGCTGTGATGGTAAATTATTGGAATCCAATTAGTGATTCAATTAACAT lined. The '# '  under an amino-acid sequence indicates a potential 
ATTTGTGATTGAGTTCATATGTCAACTCAGTATTAAAGCATCTTTTATGTGCTGGTTTTA N-linked glycosylation site in the N-terminal extracellular egion. 
ATGTCAAAATAAAAAGGATTTGAGG~ 312 4 
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3' end of the clone, suggesting that the cDNA clone A 
encompasses most of the mRNA species observed in the 200 
Northern blot (Fig. 3). Comparison of the amino-acid 
sequence of the mouse Y2 receptor to those of the mouse 150 
Y1 and Y4 receptors reveals significant differences. As g 
shown in Fig. 2, at the amino-acid level the mouse Y2 
receptor exhibits low overall identities of 27% and 26% ~ 100 ._.q 
, . . . .q -  with the Y1 and Y4 receptors, respectively. The alignment 
scores for the transmembrane (TM) domains are 42% and ~ 50 
44% identity with the Y1 and Y4 receptors, respectively. 
Interestingly, a high identity was observed in the TM2, 0 i I 
TM6 and TM7 domains of these receptors (52% with the 0.1 1 10 100 
YI receptor and 53% with the Y4 receptor). Southern blot NPY (nM) 
analysis of the mouse genomic DNA revealed the presence 
of single BamHI ,  Pst I ,  EcoRI ,  and EcoRV restriction B 
fragments, when probed with the full-length cDNA of 200 
mY2 clone (Fig. 3A). This result indicates that there is a 
single Y2 receptor gene. The expression of the receptor 
150 
mRNA in various mouse tissues was investigated by 
Northern blot analysis (Fig. 3B). Among the tissues, only 
brain showed a band in the range of about 4 kilobases. No .~ 10o 
signal was obtained from any of the other peripheral t-'- 
tissues, such as heart, spleen, lung, liver, skeletal muscle, ~ 50 
kidney, or testis. 
To examine signal transduction through the cloned re- 0 i _ i 
ceptor, the coding region of mY2 was subcloned in a 1 2 3 4 5 
Fig. 4. Intracellular Ca 2+ mobilization by NPY, NPY-(13-36), 
[Leu 31,Pro34]NPY, PYY, and PP in fura-2/AM-loaded CHO-mY2 cells. 
A 1 2 3 4 B 1 2 3 4 5 6 7 8 The cells were incubated in Hepes/Tyrode buffer containing 3 p~M 
fura-2/AM for 1.5 h at room temperature. Measurements of the intra- 
........... cellular Ca 2+ concentration n the fura-2/AM-load cells were performed 
(kbp) f~ i!i~!!{{i (kb) as described previously [9]. (a) Dose-response curve of NPY for elicit- 
23. l ' l~ .... ing an intracellular Ca 2+ increase inCHO-mY2 cells ((3). To examine 
~ 4.4-t~ the effects of PTX, PTX (50 ng/ml) was added the medium 24 h before 
9.4-~ ~ /:~ ~ii~!l~;:i the assay. The NPY (100 nM)-induced response was inhibited by PTX 
6.6-1~ 2.4-1~ !!iii~ il)~ ( . ) .  Each point is the mean+S.D, of three assays. (B)Intracellular 
Ca 2+ mobilization by pancreatic polypeptide family: lane 1, NPY (100 
4.4-t~ 'i:~iiiii ........ ~, ; nM); lane 2, [Leu31,Pro34]NpY (100 nM); lane 3, NPY-(13-36) (100 
i ii//I nM); lane 4, PYY (100 nM); and lane 5, PP (100 nM). The columns and 
........................................... ~ :, vertical bars show the mean and S.D., respectively. 
~' ; i i i  i ; i  r : : : ;  
2.3-~ } '  
mammalian expression vector (pcDNA3, Invitrogen) and 
........ transfected into CHO-K1 cells (termed CHO-mY2). In the 
CHO-mY2 cells, intracellular second messages were inves- 
Fig. 3. Southern and Northern blot analyses. (A) Southern blot analysis of tigated by measuring ligand-evoked intracellular Ca 2 + mo- 
mouse genomic DNA. Mouse genomic DNA was purchased from Clon- bility and cAMP accumulation. As shown in Fig. 4A, 
tech. It was digested with BamHI (lane 1), PstI (lane 2), EcoRI (lane 3), fura-2 pentaacetoxymethyl ester (fura-2/AM)-loaded 
or EcoRV (lane 4). The fragments were separated byelectrophoresis on CHO-mY2 cells showed a dose-dependent i crease in the 
an 0.8% agarose gel, transferred onto a nylon membrane (Nybond-N ÷, intracellular Ca 2+ concentration with the expected sensi- 
Amersham), and then hybridized with a 32 P-labeled full-length cDNA of 
mY2 as a probe. Hybridization was carried out at 65°C for 2 h in Rapid tivity to NPY (EDs0 around 2 nM). The intracellular Ca 2+ 
Hybridization Buffer (Amersham), and the filter was washed at 65°C for response was receptor-dependent, being elicited by 100 
30 min in 0.2 × SSC containing 0.1% SDS. (B) Northern blot analysis of nM NPY, PYY, and NPY-(13-36) (A[Ca 2 + ]~ = 154 _ 1 1 
the mouse Y2 receptor mRNA. Mouse Multiple Tissue Northern Blot was nM, 162 + 2 nM, and 152 ___ 15 nM (mean _ S.D., n = 3), 
purchased from Clontech. Each lane contained 2 /*g of poly(A) + RNA.  respectively), but not by 100 nM [Leu 31,Pro34]NPY or PP 
The full-length cDNA of mY2 was used as a probe. Hybridization was (Fig. 4B). Incubation of the CHO-mY2 cells with 20 /xM 
carried out at 65°C for 1 h in 1 ×SSC containing 0.1% SDS. Lane 1, 
heart; lane 2, brain; lane 3, spleen; lane 4, lung; lane 5, liver; lane 6, forskolin produced cAMP (on average 12 pmol /5  • 104 
skeletal muscle; lane 7, kidney; and lane 8, testis, cells) over a 30 min period. In these cells, forskolin- 
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A mouse NPY-Y2 receptor is functionally expressed in 
CHO-mY2 cells. When CHO-mY2 cells were treated with 
20 PTX (50 ng/ml ,  24 h), elevation of the intracellular Ca 2 + 
concentration and inhibition of forskolin-stimulated cAMP 
o 15 accumulation by NPY were eliminated (Fig. 4A and Fig. "o 
5A). This suggests that the mouse Y2 receptor couples to 
10 PTX-sensitive G-protein(s), probably Gi /Go,  in CHO cells. 
In summary, we have presented the structure and func- 
~" 5 tional expression of the mouse NPY-Y2 receptor. The 
< results of this investigation will be very useful for studying 
0 ~ , / /~  j ~ the tissue distribution of the NPY-Y2 receptor and for 
0 1 10 100 designing specific NPY agonists or antagonists for thera- 
NPY (nM) peutic purposes. 
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